FRI0008 IL-21 regulates B cell proliferation and differentiation in rheumatoid arthritis

2013 ◽  
Vol 71 (Suppl 3) ◽  
pp. 313.1-313
Author(s):  
R. Liu ◽  
Q. Wu ◽  
X. Li ◽  
L. Sun
2012 ◽  
Vol 274 (1-2) ◽  
pp. 46-53 ◽  
Author(s):  
Nan Che ◽  
Xia Li ◽  
Shiliang Zhou ◽  
Rui Liu ◽  
Dongyan Shi ◽  
...  

Cytotherapy ◽  
2014 ◽  
Vol 16 (4) ◽  
pp. S77 ◽  
Author(s):  
M. Franquesa ◽  
F. Mensah ◽  
R. Huizinga ◽  
M. Betjes ◽  
W. Weimar ◽  
...  

2007 ◽  
Vol 179 (4) ◽  
pp. 717-731 ◽  
Author(s):  
Tania Habib ◽  
Heon Park ◽  
Mark Tsang ◽  
Ignacio Moreno de Alborán ◽  
Andrea Nicks ◽  
...  

Deregulated expression of the Myc family of transcription factors (c-, N-, and L-myc) contributes to the development of many cancers by a mechanism believed to involve the stimulation of cell proliferation and inhibition of differentiation. However, using B cell–specific c-/N-myc double-knockout mice and Eμ-myc transgenic mice bred onto genetic backgrounds (recombinase-activating gene 2−/− and Btk−/− Tec−/−) whereby B cell development is arrested, we show that Myc is necessary to stimulate both proliferation and differentiation in primary B cells. Moreover, Myc expression results in sustained increases in intracellular Ca2+ ([Ca2+]i), which is required for Myc to stimulate B cell proliferation and differentiation. The increase in [Ca2+]i correlates with constitutive nuclear factor of activated T cells (NFAT) nuclear translocation, reduced Ca2+ efflux, and decreased expression of the plasma membrane Ca2+–adenosine triphosphatase (PMCA) efflux pump. Our findings demonstrate a revised model whereby Myc promotes both proliferation and differentiation, in part by a remarkable mechanism whereby Myc amplifies Ca2+ signals, thereby enabling the concurrent expression of Myc- and Ca2+-regulated target genes.


1996 ◽  
Vol 26 (3) ◽  
pp. 725-728 ◽  
Author(s):  
Fabienne Pietravalle ◽  
Sybille Lecoanet-Henchoz ◽  
Jean-Pierre Aubry ◽  
Greg Elson ◽  
Jean-Yves Bonnefoy ◽  
...  

1989 ◽  
Vol 170 (6) ◽  
pp. 2011-2022 ◽  
Author(s):  
W Mourad ◽  
P Scholl ◽  
A Diaz ◽  
R Geha ◽  
T Chatila

The Staphylococcus aureus exotoxin toxic shock syndrome toxin 1 (TSST-1) is a potent activator of T cells and monocytes. We have recently demonstrated that TSST-1 is a superantigen that binds monomorphic determinants on MHC class II molecules. In the present study, we have examined the effect of TSST-1 on the activation and differentiation of high density human tonsillar B cells. TSST-1 bound to tonsilar B cells with high affinity and saturation kinetics. This binding was effectively inhibited by a combination of anti-HLA-DR and anti-HLA-DQ mAbs. Treatment of purified B cells with TSST-1 failed to induce B cell proliferation or Ig production. However, in the presence of irradiated T cells, TSST-1 induced resting B cells to proliferate and differentiate into Ig secretory cells. TSST-1 mimicked nominal antigen in that its induction of B cell responses was strictly dependent on physical contact between T and B cells, and was profoundly inhibited by anti-MHC class II mAbs, anti-CD3 mAbs, and, to a lesser extent, by anti-CD18 mAbs. However, unlike nominal antigen, TSST-1-mediated T/B cell interactions were MHC unrestricted. These results suggest that TSST-1 induces T cell-dependent B cell proliferation and differentiation by virtue of its ability to mediate MHC-unrestricted cognate T/B cell interaction via the TCR/CD3 complex and MHC class II antigens.


2010 ◽  
Vol 40 (4) ◽  
pp. 955-965 ◽  
Author(s):  
Ferenc A. Scheeren ◽  
Anja U. van Lent ◽  
Maho Nagasawa ◽  
Kees Weijer ◽  
Hergen Spits ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document